Abstract
N-Substituted tetrazole was attempted to formylate which led to the formation of a novel triazene by opening of tetrazole ring via unusual Vilsmeir-Haack reaction. The formed product was proved by spectral analyses and X-Ray diffraction studies.
Keywords: Sydnone, triazole, terazole, formylation, iminium cation, Vilsmeir-Haack reaction.
Graphical Abstract
Letters in Organic Chemistry
Title:Ring Opening of Tetrazole via Unusual Vilsmeir-Haack Reaction Forming Novel Triazenes
Volume: 12 Issue: 2
Author(s): Atukuri Dorababu, Ravindra R. Kamble, H. C. Devarajegowda and Gangadhar Y. Meti
Affiliation:
Keywords: Sydnone, triazole, terazole, formylation, iminium cation, Vilsmeir-Haack reaction.
Abstract: N-Substituted tetrazole was attempted to formylate which led to the formation of a novel triazene by opening of tetrazole ring via unusual Vilsmeir-Haack reaction. The formed product was proved by spectral analyses and X-Ray diffraction studies.
Export Options
About this article
Cite this article as:
Dorababu Atukuri, R. Kamble Ravindra, Devarajegowda H. C. and Y. Meti Gangadhar, Ring Opening of Tetrazole via Unusual Vilsmeir-Haack Reaction Forming Novel Triazenes, Letters in Organic Chemistry 2015; 12 (2) . https://dx.doi.org/10.2174/157017861202150213102528
DOI https://dx.doi.org/10.2174/157017861202150213102528 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Molecular Insights and Therapeutic Targets in Amyotrophic Lateral Sclerosis
CNS & Neurological Disorders - Drug Targets Brain Tumor-Related Epilepsy
Current Neuropharmacology Understanding Autophagy in Cell Death Control
Current Pharmaceutical Design Phytochemistry and Pharmacognosy of Naturally Occurring Prenyloxyanthraquinones
Current Drug Targets Characteristic Alterations of Nuclear Structure and Chromatin Organisation of Cancer Cells Addressed by Proteome Analysis**
Current Proteomics Current Status Of Short Synthetic Peptides As Vaccines
Medicinal Chemistry Engineering Approaches to Develop the Next Generation of Antibodies to Respiratory Targets
Inflammation & Allergy - Drug Targets (Discontinued) Virus, Oncolytic Virus and Human Prostate Cancer
Current Cancer Drug Targets Evaluation of Direct Effect of Testosterone on NGEP and LM O1 Expression in LNCaP Prostate Cancer Cells
Current Biomarkers (Discontinued) Application of Pharmacogenomic Approaches in the Study of Drug Response in Complex Diseases
Current Pharmacogenomics On the Origin of Epidermal Cancers
Current Molecular Medicine Tyrosine Kinase Inhibitor as a new Therapy for Ischemic Stroke and other Neurologic Diseases: is there any Hope for a Better Outcome?
Current Neuropharmacology Review of the Contribution of Radiolabelled Tracers for Tumour Cell Status Imaging
Current Medical Imaging Tumoral Drug Metabolism: Perspectives and Therapeutic Implications
Current Drug Metabolism A Combination of Two Antioxidants (An SOD Mimic and Ascorbate) Produces a Pro-Oxidative Effect Forcing Escherichia coli to Adapt Via Induction of oxyR Regulon
Anti-Cancer Agents in Medicinal Chemistry Some Implications of Receptor Kinase Signaling Pathway for Development of Multitargeted Kinase Inhibitors
Current Radiopharmaceuticals Application of Metabolomics in Drug Discovery, Development and Theranostics
Current Metabolomics Potential Health Benefits of Berries
Current Nutrition & Food Science The mir-221/222 Cluster is a Key Player in Vascular Biology via the Fine-Tuning of Endothelial Cell Physiology
Current Vascular Pharmacology Exploring Proteomic Drug Targets, Therapeutic Strategies and Protein - Protein Interactions in Cancer: Mechanistic View
Current Cancer Drug Targets